FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2097478521> ?p ?o ?g. }

• W2097478521 endingPage "e16991" @default.
• W2097478521 startingPage "e16991" @default.
• W2097478521 abstract "Background Impaired insulin signalling is increasingly thought to contribute to Alzheimer's disease (AD). The ε4 isoform of the APOE gene is the greatest genetic risk factor for sporadic, late onset AD, and is also associated with risk for type 2 diabetes mellitus (T2DM). Neuropathological studies reported the highest number of AD lesions in brain tissue of ε4 diabetic patients. However other studies assessing AD pathology amongst the diabetic population have produced conflicting reports and have failed to show an increase in AD-related pathology in diabetic brain. The thiazolidinediones (TZDs), peroxisome proliferator-activated receptor gamma agonists, are peripheral insulin sensitisers used to treat T2DM. The TZD, pioglitazone, improved memory and cognitive functions in mild to moderate AD patients. Since it is not yet clear how apoE isoforms influence the development of T2DM and its progression to AD, we investigated amyloid beta and tau pathology in APOE knockout mice, carrying human APOEε3 or ε4 transgenes after diet-induced insulin resistance with and without pioglitazone treatment. Methods Male APOE knockout, APOEε3-transgenic and APOEε4-transgenic mice, together with background strain C57BL6 mice were kept on a high fat diet (HFD) or low fat diet (LFD) for 32 weeks, or were all fed HFD for 32 weeks and during the final 3 weeks animals were treated with pioglitazone or vehicle. Results All HFD animals developed hyperglycaemia with elevated plasma insulin. Tau phosphorylation was reduced at 3 epitopes (Ser396, Ser202/Thr205 and Thr231) in all HFD, compared to LFD, animals independent of APOE genotype. The introduction of pioglitazone to HFD animals led to a significant reduction in tau phosphorylation at the Ser202/Thr205 epitope in APOEε3 animals only. We found no changes in APP processing however the levels of soluble amyloid beta 40 was reduced in APOE knockout animals treated with pioglitazone." @default.
• W2097478521 created "2016-06-24" @default.
• W2097478521 creator A5002493210 @default.
• W2097478521 creator A5008977844 @default.
• W2097478521 creator A5013148431 @default.
• W2097478521 creator A5037936046 @default.
• W2097478521 creator A5085398262 @default.
• W2097478521 date "2011-02-10" @default.
• W2097478521 modified "2023-10-14" @default.
• W2097478521 title "The ε3 and ε4 Alleles of Human APOE Differentially Affect Tau Phosphorylation in Hyperinsulinemic and Pioglitazone Treated Mice" @default.
• W2097478521 cites W1508589930 @default.
• W2097478521 cites W1537531763 @default.
• W2097478521 cites W1543788907 @default.
• W2097478521 cites W1546369396 @default.
• W2097478521 cites W157753509 @default.
• W2097478521 cites W1598223536 @default.
• W2097478521 cites W1678111194 @default.
• W2097478521 cites W1802455527 @default.
• W2097478521 cites W1951826532 @default.
• W2097478521 cites W1970779072 @default.
• W2097478521 cites W1976048196 @default.
• W2097478521 cites W1979536020 @default.
• W2097478521 cites W1980151377 @default.
• W2097478521 cites W1983717670 @default.
• W2097478521 cites W1984044273 @default.
• W2097478521 cites W1985043600 @default.
• W2097478521 cites W1991157753 @default.
• W2097478521 cites W1997822484 @default.
• W2097478521 cites W1998933601 @default.
• W2097478521 cites W1999546189 @default.
• W2097478521 cites W2003275051 @default.
• W2097478521 cites W2011885704 @default.
• W2097478521 cites W2022473709 @default.
• W2097478521 cites W2022943683 @default.
• W2097478521 cites W2023899218 @default.
• W2097478521 cites W2028469996 @default.
• W2097478521 cites W2028713570 @default.
• W2097478521 cites W2031791496 @default.
• W2097478521 cites W2035825704 @default.
• W2097478521 cites W2036284058 @default.
• W2097478521 cites W2036362108 @default.
• W2097478521 cites W2037915842 @default.
• W2097478521 cites W2042584101 @default.
• W2097478521 cites W2047509507 @default.
• W2097478521 cites W2051579224 @default.
• W2097478521 cites W2056851090 @default.
• W2097478521 cites W2057042201 @default.
• W2097478521 cites W2060274086 @default.
• W2097478521 cites W2060431825 @default.
• W2097478521 cites W2062108627 @default.
• W2097478521 cites W2062968668 @default.
• W2097478521 cites W2062989356 @default.
• W2097478521 cites W2063505049 @default.
• W2097478521 cites W2066232800 @default.
• W2097478521 cites W2066673859 @default.
• W2097478521 cites W2074249519 @default.
• W2097478521 cites W2083337622 @default.
• W2097478521 cites W2084972185 @default.
• W2097478521 cites W2090881453 @default.
• W2097478521 cites W2091692749 @default.
• W2097478521 cites W2095532816 @default.
• W2097478521 cites W2098757266 @default.
• W2097478521 cites W2099271519 @default.
• W2097478521 cites W2099512544 @default.
• W2097478521 cites W2103314962 @default.
• W2097478521 cites W2106879908 @default.
• W2097478521 cites W2109958697 @default.
• W2097478521 cites W2112220590 @default.
• W2097478521 cites W2115709331 @default.
• W2097478521 cites W2131047041 @default.
• W2097478521 cites W2143360246 @default.
• W2097478521 cites W2143605092 @default.
• W2097478521 cites W2144405089 @default.
• W2097478521 cites W2148516306 @default.
• W2097478521 cites W2152420555 @default.
• W2097478521 cites W2156998090 @default.
• W2097478521 cites W2157665412 @default.
• W2097478521 cites W2159406238 @default.
• W2097478521 cites W2162846333 @default.
• W2097478521 cites W2166346463 @default.
• W2097478521 cites W2170218376 @default.
• W2097478521 cites W2171960085 @default.
• W2097478521 cites W62299013 @default.
• W2097478521 doi "https://doi.org/10.1371/journal.pone.0016991" @default.
• W2097478521 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3037394" @default.
• W2097478521 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21347323" @default.
• W2097478521 hasPublicationYear "2011" @default.
• W2097478521 type Work @default.
• W2097478521 sameAs 2097478521 @default.
• W2097478521 citedByCount "32" @default.
• W2097478521 countsByYear W20974785212012 @default.
• W2097478521 countsByYear W20974785212013 @default.
• W2097478521 countsByYear W20974785212014 @default.
• W2097478521 countsByYear W20974785212015 @default.
• W2097478521 countsByYear W20974785212016 @default.
• W2097478521 countsByYear W20974785212017 @default.
• W2097478521 countsByYear W20974785212018 @default.
• W2097478521 countsByYear W20974785212019 @default.

• next